Literature DB >> 15449000

Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging.

Hyo-Sung Kwak1, Jeong-Min Lee, Young-Kon Kim, Young Hwan Lee, Chong-Soo Kim.   

Abstract

The purpose was to compare the diagnostic accuracy of ferumoxides-enhanced MR imaging and gadolinium-enhanced dynamic MR imaging using three-dimensional (3D) volume interpolated breath-hold examination (VIBE) for the detection of hepatocellular carcinoma (HCC). Forty-nine patients with 61 HCCs, who underwent ferumoxides-enhanced and gadolinium-enhanced dynamic MR imaging, were included prospectively in this study. Ferumoxides-enhanced MR imaging was performed 24 h after completion of the dynamic study using 3D-VIBE. Three radiologists independently interpreted the images. The diagnostic accuracy was evaluated using the receiver-operating characteristic method, and the sensitivity of each imaging technique was compared using McNemar's test. The mean diagnostic accuracy of dynamic MR imaging (Az=0.95) was higher than that of ferumoxides-enhanced MR imaging (Az=0.90), but failed to reach a statistical significance (P=0.057). The mean sensitivity of dynamic MR imaging (90.7%) was significantly superior to that of ferumoxides-enhanced MR imaging (80.9%, P=0.03). Furthermore, for lesions smaller than 15 mm, the mean sensitivity of dynamic MR imaging was significantly higher than that of ferumoxides-enhanced MR imaging (85.2% vs. 69.2%, P<0.05). Dynamic MR imaging showed a trend toward better diagnostic accuracy for than ferumoxides-enhanced MR imaging for the detection of HCCs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15449000     DOI: 10.1007/s00330-004-2508-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  31 in total

1.  Liver tumors in cirrhosis: experimental study with SPIO-enhanced MR imaging.

Authors:  O Clement; G Frija; C Chambon; E Schouman-Clayes; J F Mosnier; M F Poupon; B Balkau
Journal:  Radiology       Date:  1991-07       Impact factor: 11.105

2.  Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis.

Authors:  J Ward; K S Naik; J A Guthrie; D Wilson; P J Robinson
Journal:  Radiology       Date:  1999-02       Impact factor: 11.105

3.  Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.

Authors:  Y Tang; Y Yamashita; A Arakawa; T Namimoto; K Mitsuzaki; Y Abe; K Katahira; M Takahashi
Journal:  AJR Am J Roentgenol       Date:  1999-06       Impact factor: 3.959

4.  Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents.

Authors:  H Ohishi; H Uchida; H Yoshimura; S Ohue; J Ueda; M Katsuragi; N Matsuo; Y Hosogi
Journal:  Radiology       Date:  1985-01       Impact factor: 11.105

5.  Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US.

Authors:  Thomas J Vogl; Wolfram Schwarz; Stefan Blume; Michael Pietsch; Kohkan Shamsi; Martina Franz; Hartmut Lobeck; Thomas Balzer; Kelly del Tredici; Peter Neuhaus; Roland Felix; Renate M Hammerstingl
Journal:  Eur Radiol       Date:  2002-09-10       Impact factor: 5.315

6.  Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25.

Authors:  A Denys; L Arrive; V Servois; B Dubray; D Najmark; A Sibert; Y Menu
Journal:  Radiology       Date:  1994-12       Impact factor: 11.105

7.  Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions.

Authors:  P R Ros; P C Freeny; S E Harms; S E Seltzer; P L Davis; T W Chan; A E Stillman; L R Muroff; V M Runge; M A Nissenbaum
Journal:  Radiology       Date:  1995-08       Impact factor: 11.105

8.  Preoperative depiction of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus triple-phase helical CT.

Authors:  Bo Kiung Kang; Jae Hoon Lim; Seung Hoon Kim; Dongil Choi; Hyo Keun Lim; Won Jae Lee; Soon Jin Lee
Journal:  Radiology       Date:  2003-01       Impact factor: 11.105

9.  Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions.

Authors:  Young Kon Kim; Jeong Min Lee; Chong Soo Kim
Journal:  Eur Radiol       Date:  2003-11-05       Impact factor: 5.315

10.  Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography.

Authors:  Hyo-Sung Kwak; Jeong-Min Lee; Chong-Soo Kim
Journal:  Eur Radiol       Date:  2003-10-03       Impact factor: 5.315

View more
  3 in total

1.  Small (<or=3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT.

Authors:  R Golfieri; E Marini; A Bazzocchi; F Fusco; F Trevisani; C Sama; G Mazzella; S Cavuto; F Piscaglia; L Bolondi
Journal:  Radiol Med       Date:  2009-08-20       Impact factor: 3.469

2.  Hepatocellular carcinoma: management of an increasingly common problem.

Authors:  Gary L Davis; Jane Dempster; James D Meler; Douglas W Orr; Mark W Walberg; Brian Brown; Brian D Berger; John K O'Connor; Robert M Goldstein
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-07

Review 3.  Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media.

Authors:  Carlo Bartolozzi; Laura Crocetti; Riccardo Lencioni; Dania Cioni; Clotilde Della Pina; Daniela Campani
Journal:  Eur Radiol       Date:  2007-02-16       Impact factor: 7.034

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.